HIGHLIGHTS
- who: Bradley Roberts and colleagues from the The Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University have published the Article: Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?, in the Journal: (JOURNAL)
- what: A recent review noted that this study had difficulty quantifying specific SNCA transcript expression, casting doubt on the significance of the findings . This study provides evidence that αSyn can induce or exacerbate aggregation of known ALS proteins, leading these authors to suggest that suppressing αSyn-mediated protein interaction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.